STERIS plc

STE Healthcare Medical Devices

STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025. In the quarter to June 2026, revenue grew 7.30%, EPS grew 13.9%, free cash flow fell 14.4% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten, operating cash flow growth for three.

222.66 1.67 −0.74%
Market cap
$21.9B
P/E
27.1×
Fwd P/E
23.6×
Dividend yield
1.16%
F-score
9/9
Altman Z
5.10
Beneish M
−2.68
Dividend safety
86/100

STERIS plc (STE) Debt to equity

Alert me on Debt to equity

STERIS plc's debt to equity at the end of the quarter to 30 June 2026 was 0.3×, down 0.0× from fiscal 2026 (0.3×). Over the past ten years it has ranged from 0.3× (fiscal 2026) to 0.6× (fiscal 2015) — the current reading is the lowest in ten years. That is above the Medical Devices industry median of 0.1× and above the Healthcare sector median of 0.0×.

Debt to equity, annual

Embed this chart

Annual newest first

Period Debt to equity Change
FY2026 0.3× (13.11%)
FY2025 0.3× (39.16%)
FY2024 0.5× 0.38%
FY2023 0.5× 7.18%
FY2022 0.5× 9.72%
FY2021 0.4× 25.61%
FY2020 0.3× (7.81%)
FY2019 0.4× (9.19%)
FY2018 0.4× (22.26%)
FY2017 0.5× 1.98%

Quarterly newest first

Period Debt to equity Change
Jun 2026 0.3× (2.31%)
Mar 2026 0.3× 1.36%
Dec 2025 0.3× (2.00%)
Sep 2025 0.3× (1.03%)
42 more quarters

Against its own ten years

Low 0.3× High 0.6×
Ten-year median 0.5×
Current reading's percentile 8

Debt to equity against peers

What Debt to equity is

Debt to Equity Ratio shows how much a company relies on borrowed money compared with the money its shareholders have in the business.

(Long Term Debt (Total) + Current Part of Debt) ÷ Shareholders Equity (Total)

The full definition of Debt to equity →

More on STE